Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)

被引:167
作者
Delvigne, A [1 ]
Rozenberg, S [1 ]
机构
[1] Free Univ Brussels, Hosp St Pierre, Dept Obstet & Gynaecol, IVF Ctr, Brussels, Belgium
关键词
clinical course; coasting; IVF; OHSS; treatment;
D O I
10.1093/humupd/dmg005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The ovarian hyperstimulation syndrome (OHSS) is a rare iatrogenic complication of ovarian stimulation occurring during the luteal phase or during early pregnancy. This complication is unusual as it is not the consequence of a treatment which is vital or mandatory for the patient's health. Nevertheless, it can be accompanied by severe morbidity and may even be fatal. Data pertaining to the clinical course and consequences of OHSS in women and its treatment were searched using Medline, Current Contents and PubMed. To date, only a few studies have collected a large number of cases of OHSS. The clinical course of OHSS may involve, according to its severity and the occurrence of pregnancy, electrolytic imbalance, neurohormonal and haemodynamic changes, pulmonary manifestations, liver dysfunction, hypoglobulinaemia, febrile morbidity, thromboembolic phenomena, neurological manifestations and adnexal torsion. Treatment of the acute phase relies only on an empirical and symptomatic approach. The general approach will be adapted to the levels of severity. Specific approaches such as paracentesis, pleural puncture, surgical approach of OHSS and specific medication during OHSS were evaluated sporadically. More adequate treatment methods would require a better understanding of the underlying pathophysiological mechanisms, to promote an aetiological therapeutic approach. Properly conducted studies, including large numbers of patients are required in order to determine the best method of prevention and management.
引用
收藏
页码:77 / 96
页数:20
相关论文
共 221 条
[71]  
FIGUEROACASAS P, 1958, ANN CIRUG, V23, P116
[72]   An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome [J].
Fluker, MR ;
Copeland, JE ;
Yuzpe, AA .
FERTILITY AND STERILITY, 2000, 73 (04) :821-824
[73]  
FORMAN RG, 1990, FERTIL STERIL, V53, P502
[74]  
FOURNET N, 1991, FERTIL STERIL, V56, P354
[75]   Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women [J].
Fowler, PA ;
Sorsa, T ;
Harris, WJ ;
Knight, PG ;
Mason, HD .
HUMAN REPRODUCTION, 2001, 16 (07) :1353-1358
[76]   Unilateral hydrothorax as a sole and recurrent manifestation of ovarian hyperstimulation syndrome following in-vitro fertilization [J].
Friedler, S ;
Rachstein, A ;
Bukovsky, I ;
Ron-El, R ;
Raziel, A .
HUMAN REPRODUCTION, 1998, 13 (04) :859-861
[77]  
FUKAYA T, 1994, FERTIL STERIL, V61, P561
[78]   Efficacy of hydroxyethyl starch and Haemaccel for the treatment of severe ovarian hyperstimulation syndrome [J].
Gamzu, R ;
Almog, B ;
Levin, Y ;
Avni, A ;
Lessing, JB ;
Baram, A .
FERTILITY AND STERILITY, 2002, 77 (06) :1302-1303
[79]  
GERGELY RZ, 1976, OBSTET GYNECOL, V47, P83
[80]  
Germond M, 1996, HUM REPROD, V11, P1173